Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
ANI Pharmaceuticals, Inc. (ANIP) had Receiveable Turnover of 3.00 for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
$486.82M |
|
$17.15M |
|
$181.51M |
|
$305.30M |
|
$439.85M |
|
$46.97M |
|
$-27.10M |
|
$19.87M |
|
$19.87M |
|
$18.78M |
|
$18.78M |
|
$18.78M |
|
$18.78M |
|
$46.97M |
|
$106.76M |
|
18.00M |
|
18.19M |
|
$0.86 |
|
$0.85 |
|
Balance Sheet Financials | |
$519.82M |
|
$44.59M |
|
$384.61M |
|
$904.42M |
|
$145.48M |
|
$284.82M |
|
$301.35M |
|
$446.82M |
|
$432.75M |
|
$220.37M |
|
$457.60M |
|
20.48M |
|
Cash Flow Statement Financials | |
$118.96M |
|
$-18.51M |
|
$67.44M |
|
$53.23M |
|
$221.12M |
|
$167.89M |
|
$20.65M |
|
-- |
|
$-1.62M |
|
Fundamental Metrics & Ratios | |
3.57 |
|
-- |
|
-- |
|
0.38 |
|
0.62 |
|
62.71% |
|
9.65% |
|
9.65% |
|
21.93% |
|
4.08% |
|
3.52% |
|
$110.09M |
|
-- |
|
-- |
|
-- |
|
0.54 |
|
1.63 |
|
Receiveable Turnover |
3.00 |
121.52 |
|
4.34% |
|
8.52% |
|
2.08% |
|
2.53% |
|
$22.35 |
|
$6.05 |
|
$6.54 |